What’s the current market cap for HCA Healthcare stock?

HCA Healthcare (HCA) has a market cap of $87bn as of June 16, 2026.

What is the P/E ratio for HCA Healthcare stock?

The price to earnings (P/E) ratio for HCA Healthcare (HCA) stock is 13.41 as of June 16, 2026.

Does HCA Healthcare stock pay dividends?

Yes, the HCA Healthcare (HCA) stock pays dividends to shareholders. As of June 16, 2026, the dividend rate is $2.94 and the yield is 0.8%. HCA Healthcare has a payout ratio of 10.04% on a trailing twelve-month basis.

When is the next HCA Healthcare dividend payment date?

The next HCA Healthcare (HCA) dividend payment is scheduled for June 30, 2026.

What is the beta indicator for HCA Healthcare?

HCA Healthcare (HCA) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy HCA Healthcare stock | $HCA Share Price

About HCA Healthcare

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.

Ticker

$HCA

Sector

Health

Primary listing

NYSE

Employees

-

Headquarters

Nashville, United States

Website

www.hcahealthcare.com

HCA Healthcare Metrics

BasicAdvanced

$87bn

13.41

$29.07

1.19

$2.94

0.80%

What the Analysts think about HCA Healthcare

Analyst ratings (Buy, Hold, Sell) for HCA Healthcare stock.

Bulls say / Bears say

HCA forecast 2026 profit in a range of $29.10 to $31.50 per share, above the $29.46 consensus, driven by a $400 million cost-savings program through advanced analytics and automation initiatives (Reuters).

First-quarter 2026 revenue rose 4.3% year-over-year to $19.11 billion, slightly beating the $19.10 billion consensus, underpinned by sustained demand for non-urgent procedures among insured patients (Reuters).

In January 2026, the company authorized a $10 billion share repurchase program, reflecting management’s confidence in its free cash flow generation and capital allocation priorities (Reuters).

Patient admissions dipped during the 2026 flu season as respiratory-related admissions fell 42% and emergency room visits dropped 32%, fueling an 8% pre-market share decline after first-quarter results (Reuters).

Bank of America downgraded HCA to “neutral” from “buy”, citing cuts to Medicaid funding and the expiration of enhanced ACA subsidies that are expected to reduce patient volumes and increase uncompensated care costs (Reuters).

Last year’s GOP tax-and-spending law will cut federal Medicaid funding by nearly $1 trillion over the next decade, amplifying reimbursement pressure and elevating bad-debt risks for hospital operators like HCA (Axios).

Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2026.

HCA Healthcare Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

HCA Healthcare Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

HCA Healthcare News

AllArticlesVideos

Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit

MarketBeat·1 day ago

HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions

Business Wire·3 weeks ago

HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative

Business Wire·4 weeks ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.